•
Dec 31, 2022

Stoke Therapeutics Q4 2022 Earnings Report

Total Revenue
$3.27M
EPS
-$0.65
Previous year: -$0.66
-1.5%
Gross Profit
$2.12M
Cash and Equivalents
$114M
Previous year: $145M
-21.6%
Free Cash Flow
-$22.8M
Previous year: -$16.5M
+38.4%
Total Assets
$256M
Previous year: $239M
+7.2%

Stoke Therapeutics

Stoke Therapeutics

Stoke Therapeutics Revenue by Segment